# Trace Element Replenishment Study in Hemodialysis Patients

Study · id `cardio:ct-nct01473914` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01473914](<https://clinicaltrials.gov/study/NCT01473914>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01473914

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.

## Technical summary

Registry record NCT01473914. Randomized; quadruple masking; primary purpose treatment. Start 2012-11 (registry gives no type); primary completion 2013-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 150 participants (enrolled count; ClinicalTrials.gov record NCT01473914, source copy `cardio:ctgov-nct01473914-2016-12-16`, retrieved 2026-10-26)
- Start date: 2012-11 (registry gives no type) (ClinicalTrials.gov record NCT01473914, source copy `cardio:ctgov-nct01473914-2016-12-16`, retrieved 2026-10-26)
- Primary completion: 2013-12 (actual) (ClinicalTrials.gov record NCT01473914, source copy `cardio:ctgov-nct01473914-2016-12-16`, retrieved 2026-10-26)
- Completion: 2014-01 (actual) (ClinicalTrials.gov record NCT01473914, source copy `cardio:ctgov-nct01473914-2016-12-16`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT01473914, source copy `cardio:ctgov-nct01473914-2016-12-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01473914-2016-12-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Trace Element Replenishment Study in Hemodialysis Patients
- Condition: End Stage Renal Disease
- Intervention (Dietary supplement): Low dose: supplemental zinc, selenium and vitamin E
- Intervention (Dietary supplement): Standard renal vitamin: B and C renal vitamin
- Intervention (Dietary supplement): Medium dose: supplemental zinc, selenium and vitamin E
- Lead sponsor: Marcello Tonelli
- Lead sponsor class: OTHER
- Collaborator: Alberta Health services
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as a collaborator: Alberta Health services (`cardio:org-alberta-health-services`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: Trace element supplementation in hemodialysis patients: a randomized controlled trial (`cardio:pubmed-25884981`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 5537107ff12658da7fee2ee214414ac4e2108e85f12d96645cd7a5c562a0eee3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
